Literature DB >> 11066076

t(7;12)(q36;p13), a new recurrent translocation involving ETV6 in infant leukemia.

S Tosi1, J Harbott, A Teigler-Schlegel, O A Haas, H Pirc-Danoewinata, C J Harrison, A Biondi, G Cazzaniga, H Kempski, S W Scherer, L Kearney.   

Abstract

The ETV6 gene is rearranged as a result of translocations involving a wide variety of chromosomal partners. To date, 12 partner genes for ETV6 have been cloned, and a further 23 chromosomal regions have been described. We previously identified a cryptic t(7;12) with ETV6 involvement in two cases of infant leukemia. The finding of a third case of t(7;12), also in an infant, prompted a more focussed search based on the common features found in these patients and those reported in the literature. The selection criteria were age at diagnosis < 20 months and the presence of +19 and/or +8 in the karyotype; cases with abnormalities of 7q and/or 12p were also considered. FISH studies using whole chromosome paints and probes for the ETV6 gene revealed a t(7;12) in 10 out of 23 cases studied. Seven of these had evidence of ETV6 rearrangement. Of those with ETV6 involvement, six had a 7q36 and one a 7q22 breakpoint. Importantly, in three cases the 7q36 breakpoint was within the same PAC, suggesting the existence of a new nonrandom translocation. However, in at least one patient the 7q36 breakpoint was different. The identification of the 7q partner genes will determine whether it is the disruption of ETV6 alone, or the formation of fusion genes, that is important for leukemogenesis in these patients. As both 7q36 and 7q22 are critical regions of gene loss in del(7q) leukemias, the identification of partner genes from these regions may also be important in understanding the pathogenesis of these diseases. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11066076     DOI: 10.1002/1098-2264(2000)9999:9999<::aid-gcc1039>3.0.co;2-9

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  9 in total

1.  Genetic alterations in children and adolescents with acute myeloid leukaemia.

Authors:  Amparo Verdeguer
Journal:  Clin Transl Oncol       Date:  2010-09       Impact factor: 3.405

2.  Homeobox protein HB9 binds to the prostaglandin E receptor 2 promoter and inhibits intracellular cAMP mobilization in leukemic cells.

Authors:  Sarah Wildenhain; Deborah Ingenhag; Christian Ruckert; Özer Degistirici; Martin Dugas; Roland Meisel; Julia Hauer; Arndt Borkhardt
Journal:  J Biol Chem       Date:  2012-10-08       Impact factor: 5.157

3.  Novel insights into the role of aberrantly expressed MNX1 (HLXB9) in infant acute myeloid leukemia.

Authors:  Juerg Schwaller
Journal:  Haematologica       Date:  2019-01       Impact factor: 9.941

Review 4.  Acute myeloid leukemia in infants: biology and treatment.

Authors:  Riccardo Masetti; Francesca Vendemini; Daniele Zama; Carlotta Biagi; Andrea Pession; Franco Locatelli
Journal:  Front Pediatr       Date:  2015-04-28       Impact factor: 3.418

Review 5.  Acute myeloid leukaemia at an early age: Reviewing the interaction between pesticide exposure and KMT2A-rearrangement.

Authors:  Maria S Pombo-de-Oliveira; Francianne Gomes Andrade; Gisele Dallapicola Brisson; Filipe Vicente Dos Santos Bueno; Ingrid Sardou Cezar; Elda Pereira Noronha
Journal:  Ecancermedicalscience       Date:  2017-11-30

6.  The homeobox transcription factor HB9 induces senescence and blocks differentiation in hematopoietic stem and progenitor cells.

Authors:  Deborah Ingenhag; Sven Reister; Franziska Auer; Sanil Bhatia; Sarah Wildenhain; Daniel Picard; Marc Remke; Jessica I Hoell; Andreas Kloetgen; Dennis Sohn; Reiner U Jänicke; Gesine Koegler; Arndt Borkhardt; Julia Hauer
Journal:  Haematologica       Date:  2018-08-09       Impact factor: 9.941

7.  Engineered model of t(7;12)(q36;p13) AML recapitulates patient-specific features and gene expression profiles.

Authors:  Denise Ragusa; Ylenia Cicirò; Concetta Federico; Salvatore Saccone; Francesca Bruno; Reza Saeedi; Cristina Sisu; Cristina Pina; Arturo Sala; Sabrina Tosi
Journal:  Oncogenesis       Date:  2022-09-03       Impact factor: 6.524

8.  A Novel Three-Colour Fluorescence in Situ Hybridization Approach for the Detection of t(7;12)(q36;p13) in Acute Myeloid Leukaemia Reveals New Cryptic Three Way Translocation t(7;12;16).

Authors:  Abdulbasit Naiel; Michael Vetter; Olga Plekhanova; Elena Fleischman; Olga Sokova; Grigory Tsaur; Jochen Harbott; Sabrina Tosi
Journal:  Cancers (Basel)       Date:  2013-03-11       Impact factor: 6.639

Review 9.  Paediatric acute myeloid leukaemia with the t(7;12)(q36;p13) rearrangement: a review of the biological and clinical management aspects.

Authors:  Sabrina Tosi; Yasser Mostafa Kamel; Temitayo Owoka; Concetta Federico; Tony H Truong; Salvatore Saccone
Journal:  Biomark Res       Date:  2015-10-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.